Inside Look at Sola...
Health Care: Drugs
ARCA biopharma Inc. (ABIO: NASDAQ)
$1.04 0.00 | 0.00%
02/09/12 - 03:58 PM ET
85.30K / 192.10K
Vol / Avg. Vol:1.03 / 1.04
Open / Prev. Close:1.03 - 1.05
Today's Range:0.95 - 3.20
52 Wk Range:4.00%
Performance YTD:TheStreet Rating:
Portfolios with ABIO
- Portfolio NameUser Type
- Userbuddy62370 Portfolio 1
- UserKumaran
- UserSUPRATRADE NEW-BUY LIST-240...
Latest ABIO Headlines from TheStreet
- InfoLogix, Netlist: Midday Volume Plays 05.17.10 | 01:05 pm
- Arca BioPharma Patent Deja Vu: BioBuzz 03.29.10 | 06:03 am
- Sirius XM, ARCA biopharma: Early Volume Plays 03.26.10 | 09:03 am
- Brazilian Telecom, Agria: Midday Volume Plays 11.24.09 | 01:11 pm
- ARCA, FortuNet: Midday Volume Plays 11.23.09 | 01:11 pm
- Funds Sell $4M Worth of Pain Therapeutics 06.11.09 | 09:06 am
- Ford, Deere, Cisco Systems Are Big Movers 06.01.09 | 05:06 pm
- FDA Wants ARCA To Run More Tests On Heart Drug 06.01.09 | 11:06 am
- The Second Dendreon Wave
05.18.09 | 02:05 pm
Press Releases for ABIO
- ARCA Biopharma Announces Additional Patent Issued For Methods For Treatment With Bucindolol Based On Genotype Of Patient - Business Wire 01.19.12 | 08:01 am
- CEO Of ARCA Biopharma To Speak On Use Of Biomarkers And Implications Of Personalized Medicine At New Paradigms Conference On January 12, 2012 - Business Wire 01.05.12 | 08:01 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 12.30.11 | 08:12 am
- ARCA Biopharma Announces Private Placement Of $1.75 Million With Institutional Investors - Business Wire 12.22.11 | 08:12 am
- Kaplan Meier Curves By Beta-1 389 Arg/Gly Polymorphism. (Graphic: Business Wire) - Business Wire 11.16.11 | 11:11 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 11.11.11 | 08:11 am
- Two GencaroTM Atrial Fibrillation Abstracts Accepted For Presentation At The American Heart Association Scientific Sessions 2011 - Business Wire 08.10.11 | 08:08 am
- ARCA Biopharma Announces Planned Expansion Of Gencaro Development To Atrial Fibrillation - Business Wire 05.26.11 | 08:05 am
- CEO Of ARCA Biopharma To Present Gencaro Development Programs At The European Society Of Cardiology’s Heart Failure Congress 2011 - Business Wire 05.16.11 | 08:05 am
- ARCA Biopharma Signs Global Rights Agreement With Large Pharma Company For One Of ARCA’s Early Stage Assets - Business Wire 05.03.11 | 08:05 am
Partner Headlines for ABIO
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY) - Benzinga 05.13.11 | 02:05 pm
- Morning Market Movers (ABIO, LBIX, CGNX, AEIS) - Benzinga 05.03.11 | 09:05 am
- UPDATE 1-Arca reaches agreement with FDA on heart-drug study - Reuters 05.17.10 | 09:05 am
- UPDATE 1-ARCA gets U.S. patent related to heart drug; shrs soar - Reuters 03.26.10 | 10:03 am
